Primary Insulin Hypersecretion Clinical Trials
A listing of Primary Insulin Hypersecretion medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 47 clinical trials
4D-flow Cardiac MRI to Assess Pulmonary Arterial Pressure in Pulmonary Hypertension
Due to radiation exposure and low but real risk of morbidity and mortality associated with right heart catheterization, non-invasive procedures to estimate mPAP are desired for the diagnosis of PH or to monitor treatment effectiveness. Echocardiography is used as a screening tool to estimate systolic pulmonary arterial pressure (sPAP), but …
- 0 views
- 19 Nov, 2021
- 1 location
Evaluation of the Usefulness of Adopting Remote Mobile-based 6MWT Among Hospital Outpatients (the 6-APPnow) Within the Constraints Imposed by the SARS-COV2 Pandemic
The six-minute walk test (6MWT) is a standard method for measuring exercise capacity in patients with cardiopulmonary disease such as pulmonary hypertension (PAH) and measures how far a patient can walk in 6 minutes. The test is usually performed in the hospital, by walking along a hospital corridor. Since the …
- 6 views
- 06 Nov, 2021
- 1 location
Giessen Pulmonary Hypertension Registry and Biobank
Giessen Pulmonary Hypertension Registry and Biobank
- 3 views
- 16 Feb, 2022
- 1 location
Prospective Registry and Biobank for Long-term Observational Studies in Adult Patients With Pulmonary Hypertension
Prospective registry and biobank for long-term observational studies in adult patients with pulmonary hypertension
- 0 views
- 16 Feb, 2021
- 1 location
Database for Clinical and Anamnestic Data in Pulmonary Hypertension
Pulmonary hypertension (PH) is defined as a pulmonary arterial mean pressure (meanPAP) 25 mmHg measured in the right heart catheterization. There are different forms of PH defined in the classification of Dana Point 2008. PH is diagnosed with right heart catheterization but there are other non invasive methods which can …
- 1 views
- 27 Jan, 2021
- 1 location
COMPERA / COMPERA-KIDS (COMPERA)
In view of the manifold options for mono- and combination therapy that have now emerged for patients with pulmonary (arterial) hypertension (PH/PAH), controlled clinical trials can only provide part of the information needed for optimal management. In order to gather adequate data on PAH/PH treatment in routine clinical care, the …
- 46 views
- 25 Mar, 2022
- 7 locations
Drug Use Investigation of Riociguat for Pulmonary Arterial Hypertension (PAH) (JPMS-PAH)
The primary objective in this study is to collect post-marketing information on Riociguat safety.Thus, the information on adverse events (AEs) and adverse drug reactions (ADRs) that occur within the first 12 months and in the following 6 -year observation at most, after starting Riociguat treatment under the routine clinical practice …
- 10 views
- 18 Oct, 2022
- 1 location
Drug Use Investigation of Riociguat for ChronicThromboembolic Pulmonary Hypertension (CTEPH) (JPMS-CTEPH)
This local, prospective, non-interventional, multi-center study includes patients treated with Riociguat for inoperable CTEPH(Chronic thromboembolic pulmonary hypertension)/ persistent or recurrent CTEPH after surgical treatment. It is planned to include a total of 400 patients (valid for safety analysis). This study is performed as an all-case investigation. The treatment of Riociguat …
- 7 views
- 22 Oct, 2022
- 1 location
Registration Study for Rare Type of Pulmonary Hypertension
The knowledge on the rare type of pulmonary hypertension which can not be explained by left heart disease, respiratory disease or congenital heart disease is very limited. Investigators aim to setup a national registration study for the rare type of pulmonary hypertension, to understand the natural history, survival, progression, genetic …
- 1 views
- 04 Oct, 2022
- 1 location
Pulmonary Hypertension Association Registry (PHAR)
The PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). PHAR collects information from people with PAH and CTEPH who are cared for in participating PHA-accredited Pulmonary Hypertension Care Centers throughout the U.S. PHAR will determine how people …
- 767 views
- 03 Mar, 2022
- 49 locations